Ontrak Corp - OTRK Year-over-year earnings per share growth for the last twelve months

Ontrak, Inc. (OTRK) is developing an AI system for the predictive analysis of mental pathologies, which the GURU.Markets platform reflects via a quarterly earnings per share chart. The team unites psychologists and IT professionals under a common mission, yet debts and declining revenue are forcing cost reductions. In this price action, -0.30 serves as the final level marker, helping to filter speculative noise from the actual trend.

Ontrak (OTRK) - Quarterly EPS earnings growth from 07/04/2022 to 08/30/2025

Ontrak, Inc. (OTRK) - metric breakdowns and financial figures

- share price and consensus valuation forecast:

Stock Quotes Ontrak|OTRK - Analyst Forecast Prices

- issuer market value details:

Market Value Ontrak, Inc.|OTRK - Value Adjusted for Debt and Cash

- book capitalization data:

Book Value per Share Ontrak|OTRK - Book Capitalization|Market Value to Book Value Ratio ontrak-inc.com|OTRK - Company Total Assets

- business debt structure and liquidity details:

- earnings and valuation multiples indicators:

OTRK - Net Financial Result|Expected Profit Ontrak, Inc.|OTRK - Market Cap to Earnings|Projected Price to Earnings Catasys|OTRK - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ontrak, Inc.|OTRK - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Ontrak|OTRK - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months ontrak-inc.com|OTRK - Net earnings per one share growth for the current year|Earnings growth forecast for next year Ontrak, Inc.

- revenue and sales details:

OTRK - Company Total Revenue|Company Projected Revenue Catasys|OTRK - Price-to-Revenue Ratio|Forward P/S Multiple Catasys|OTRK - Trailing Twelve Months Revenue Growth

Analysis of all company metrics:Ontrak, Inc.

Rising demand from insurance companies for Ontrak, Inc. (OTRK) AI platforms to optimize costs for chronic patients creates a foundation for business scaling. By analyzing the quarterly EPS trajectory, an investor assesses net income per share dynamics, which allows for the differentiation of overvalued assets from fundamentally resilient issuers with high revenue expansion potential, thereby minimizing the risk of capital drawdowns.

Key competitors

Hers (HIMS) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months HNGE|TDOC (Teladoc Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth talkspace.com|Year-over-year earnings per share growth for the last twelve months LifeMD Inc. (LFMD)|Year-over-year net earnings per share change for the last twelve months Amwell|Quarterly EPS earnings growth MGRX (Mangoceuticals, Inc.)|Year-over-year earnings per one share growth for the last 12 months DRIO|VSee - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Mobile-health (MNDR)|ACCD: Quarterly EPS earnings growth|BTCY - Year-over-year net earnings per share change for the last twelve months|LYT (Lytus Technologies Corp) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months SHL Telemedicine Ltd. (SHLT)|Quarterly EPS earnings growth THRN